Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.05 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |